It has been shown that activation of Src actively participates in early stage (ER-negative) breast cancer initiation, whereas downregulation of Src significantly inhibits cancer progression involving various underlying mechanisms such as suppression of Myc translation, reduction of GLUT1 transcription, and glucose uptake by tumor cells. This evidence concerns the gene SRC and cancer.